Alejandro Chavez, Professor of Pathology & Cell Biology at Columbia University Medical Center
Project involves screening for COVID19 protease inhibitors. We have a method of screening that lets us simultaneously examine the activity of a drug on dozens of proteases at a time. We are searching for not only a SARS-CoV-2 inhibitor but one that also shows broad activity to other coronavirus proteases.
